Laura Turner

Laura Turner counsels life sciences and healthcare industry clients on a broad range of matters, including government price reporting, fraud and abuse compliance, legislative matters, and general regulatory issues. She advises clients on Medicaid, Medicare Part B, Department of Veterans Affairs, and 340B requirements, as well as the Anti-Kickback Statute, state drug price reporting and transparency laws, and healthcare transactions. Laura also counsels clients on complex arrangements between manufacturers and specialty pharmacies, pharmacy benefit managers, managed care companies, and group purchasing agreements.

Laura has significant healthcare industry experience from her eleven years serving at a major pharmaceutical, medical device, and consumer health company. While there, she wrote, negotiated, and managed Fee-for-Service contracts. Prior to that role, she performed government pricing calculations, analyzed the impact of policy changes, and developed treatments for novel scenarios in drug pricing. Laura was instrumental in implementing a new government pricing system and developing calculation methodologies. Before that, she graduated from the company's finance leadership development program and held several roles of increasing responsibility in finance across international alliance management, sales and marketing, forecasting, and budgeting. Laura also worked as a legislative aide at a New Jersey state legislative office.

Laura graduated cum laude from Rutgers Law School, where she served as a Legal Analysis, Writing, and Research Teaching Fellow, authored an article on state prescription drug price transparency laws, and assisted with the Rutgers Law Domestic Violence Clinic. Laura graduated magna cum laude from The College of New Jersey with a degree in finance and minor in law, politics, and philosophy. Laura received her certificate in Project Management from Georgetown University and is a Certified Management Accountant.